Stingray Therapeutics, Inc.
Biotechnology company · Dallas, Texas, United States
Stingray Therapeutics, Inc. is a biotechnology company headquartered in Dallas, Texas, United States. Its earliest recorded incorporation is in 2018. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $3.5 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $25,000 sold in a notice filed in 2024.
Stingray Therapeutics at a glance
What does Stingray Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $3.5 million in total (2022 to 2025). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $25,000 sold (2024).
Frequently asked questions about Stingray Therapeutics
Where is Stingray Therapeutics headquartered?
Stingray Therapeutics, Inc. is headquartered in Dallas, Texas, United States.
What does Stingray Therapeutics do?
Stingray Therapeutics, Inc. is a biotechnology company.
When was Stingray Therapeutics founded?
The earliest incorporation on record for Stingray Therapeutics, Inc. is in 2018, according to public company registers.
Similar companies
- Spectral MD, Inc.Dallas, Texas, United States
- OncoNano Medicine, Inc.Dallas, Texas, United States
- Taysha Gene Therapies, Inc.Dallas, Texas, United States
- Sonara Health, Inc.Dallas, Texas, United States
- Instil Bio, Inc.Dallas, Texas, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.